Martin J R, Johnson P, Tadanier J, Goldstein A W
J Antibiot (Tokyo). 1980 Aug;33(8):810-8. doi: 10.7164/antibiotics.33.810.
The synthesis of 2-deoxyfortimicins A (15) and B (11) and 1-deamino-2-deoxy-2-epi-amino-fortimicins A (18) and B (12) is described. Two routes have been developed for synthesis of the key intermediate 2-O-methanesulfonylfortimicin B (7). One route involves selective blocking of fortimicin B with B-benzyloxycarbonyl groups followed by formation of a 4,5-salicylaldehyde oxazolidine derivative. Subsequent mesylation followed by deblocking gave 7. A more efficient route to 7 involves concomitant salicylaldehyde Schiff base and 4,5-oxazolidine formation followed by mesylation and hydrolysis. The formation of 1,2(R)-epiminofortimicin B (8) from 7 followed by RANEY nickel reduction gave 2-deoxyfortimicin B and 1-deamino-2-deoxy-2-epi-aminofortimicin B, which were converted to the corresponding fortimicin A derivative by selective N-blocking, N-acylation and subsequent deblocking. The antibacterial activities of the new fortimicin A derivatives are presented.
描述了2-脱氧福提霉素A(15)和B(11)以及1-脱氨基-2-脱氧-2-表氨基福提霉素A(18)和B(12)的合成。已开发出两条合成关键中间体2-O-甲磺酰基福提霉素B(7)的路线。一条路线包括用B-苄氧羰基选择性保护福提霉素B,随后形成4,5-水杨醛恶唑烷衍生物。随后进行甲磺酰化,然后脱保护得到7。一条更有效的合成7的路线包括同时形成水杨醛席夫碱和4,5-恶唑烷,随后进行甲磺酰化和水解。由7形成1,2(R)-表氨基福提霉素B(8),随后经阮内镍还原得到2-脱氧福提霉素B和1-脱氨基-2-脱氧-2-表氨基福提霉素B,通过选择性N-保护、N-酰化和随后的脱保护将它们转化为相应的福提霉素A衍生物。展示了新福提霉素A衍生物的抗菌活性。